Curaleaf Holdings, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Boris Alexis Jordan
- Full Time Employees
- 5,554
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 290 Harbor Drive Stamford CT United States of America 06902
- IPO Date
- Oct 29, 2018
- CIK
- 0001756770
- Website
- curaleaf.com
- Similar Companies
- Business
- Curaleaf Holdings, Inc. is a leading vertically integrated cannabis company engaged in the cultivation, processing, manufacturing, and distribution of cannabis products primarily in the United States, with expanding international operations. Founded in 2010 and headquartered in New York City, Curaleaf operates across approximately 17 states in the U.S., with a substantial footprint consisting of 151 dispensaries, 19 cultivation sites, and 20 manufacturing facilities. The company's product portfolio includes cannabis flower, pre-rolls, flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing and dabbing, including pre-filled cartridges and disposable pens, as well as edibles, tinctures, topicals, mints, lozenges, capsules, and hemp-derived products such as cannabidiol (CBD) and cannabigerol (CBG) items. Curaleaf serves both medical and adult-use markets through its diverse brands including Curaleaf, Select, Grassroots, JAMS, Find, The Hemp Company, and Zero Proof. In the last 1-2 years, Curaleaf has pursued aggressive expansion and innovation strategies. The company launched a new pre-roll brand and expanded its hemp-derived beverage line with new products including Select Zero Proof seltzers and The Hemp Co. hemp-derived THC seltzers distributed in multiple states through major retailers such as Total Wine. Curaleaf also introduced the Reef flower brand in Florida and expanded retail operations with new dispensaries opening in key growth states such as Florida and New York. Financially, Curaleaf secured a $40 million revolving credit facility with a major commercial regional bank, marking a significant milestone in cannabis company financing. The company’s strategic direction focuses on organic growth, margin optimization, international expansion, and deployment of advanced technology platforms such as ACE for operational improvements. Curaleaf’s recent initiatives reflect its positioning as the largest cannabis company by revenue in the U.S., operating in highly regulated populous states with an emphasis on product innovation and quality assurance. Curaleaf’s business model relies on vertical integration, controlling its supply chain from cultivation through retail, ensuring product quality and cost efficiency. It targets a broad consumer base comprising medical patients and recreational users, catering to diverse preferences through a wide range of premium cannabis-derived products. The company is known for its rigorous safety, efficacy, and consistency standards upheld through extensive research and development. Curaleaf continues to expand its retail footprint and manufacturing capacity to consolidate leadership in the multi-state operator (MSO) cannabis market while advancing its hemp division and international sales. Its operations emphasize compliance with regulatory frameworks and fostering industry education and advocacy in the evolving cannabis sector. Curaleaf employs approximately 5,500 staff and reports annual revenues of approximately $1.3 billion, maintaining strong cash flow generation despite market challenges. This description reflects Curaleaf Holdings, Inc.’s current industry standing, business activities, product range, geographic presence, and recent strategic developments as of late 2025.
Company News
Curaleaf Grows Florida Retail Presence with Riverview Dispensary Opening
Curaleaf Announces September 2026 Conference Participation
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
Aurora Cannabis Calls Curaleaf Offer Inadequate, Urges Rejection
Curaleaf Opens Boston Dispensary Near Downtown Crossing, Expanding Access for Patients in Massachusetts
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
Wall Street Analysts Predict a 43.69% Upside in Curaleaf Holdings, Inc. (CURLF): Here's What You Should Know
Curaleaf Expands Florida Reach with Cutler Bay Dispensary Opening
Curaleaf Expands Florida Reach with Cutler Bay Dispensary Opening
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid?
Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID
The Cannabis M&A Wave Is Here. Curaleaf Proved It.
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.
Curaleaf CEO talks unsolicited offer to buy Aurora Cannabis
Curaleaf Launches Take-Over Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender to the Bid
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?